Talk to us
News & activities
Simultaneous assessment of drug mechanisms and infusion reactions
17/12, 2020
The Immuneed platform is central to a new paper published in International Immunopharmacology. The study explored the donor-specific immune effector signatures of chronic lymphoid lymphoma (CLL) patients in response to anti-CD20 (Rituxi***). On a wider level, however, the study indicates the potential in analyzing multiple mecha...
Meet the Team: Louise - Lab Engineer
5/10, 2020
As Immuneed’s pool of customers and projects grows, work in the lab is intensifying. Louise Nilsson recently joined the team, so we took a moment to get her thoughts about her new role and workplace.
Introducing our new CEO!
16/9, 2020
We're pleased to announce that we've appointed Camilla Oldgren as new CEO. Click to read how she will lead the company into the preclinical testing spotlight.
1
2
3
4
We use cookies on this site to provide you with a great user experience. By using immuneed.com you agree to our terms and conditions!
